297 related articles for article (PubMed ID: 33670497)
21. Colon 26 adenocarcinoma (C26)-induced cancer cachexia impairs skeletal muscle mitochondrial function and content.
Neyroud D; Nosacka RL; Judge AR; Hepple RT
J Muscle Res Cell Motil; 2019 Mar; 40(1):59-65. PubMed ID: 30945134
[TBL] [Abstract][Full Text] [Related]
22. The emerging role of skeletal muscle oxidative metabolism as a biological target and cellular regulator of cancer-induced muscle wasting.
Carson JA; Hardee JP; VanderVeen BN
Semin Cell Dev Biol; 2016 Jun; 54():53-67. PubMed ID: 26593326
[TBL] [Abstract][Full Text] [Related]
23. Aerobic and resistance training dependent skeletal muscle plasticity in the colon-26 murine model of cancer cachexia.
Khamoui AV; Park BS; Kim DH; Yeh MC; Oh SL; Elam ML; Jo E; Arjmandi BH; Salazar G; Grant SC; Contreras RJ; Lee WJ; Kim JS
Metabolism; 2016 May; 65(5):685-698. PubMed ID: 27085776
[TBL] [Abstract][Full Text] [Related]
24. Mitochondrial plasticity in cancer-related muscle wasting: potential approaches for its management.
Vitorino R; Moreira-Gonçalves D; Ferreira R
Curr Opin Clin Nutr Metab Care; 2015 May; 18(3):226-33. PubMed ID: 25783794
[TBL] [Abstract][Full Text] [Related]
25. Tumour-derived leukaemia inhibitory factor is a major driver of cancer cachexia and morbidity in C26 tumour-bearing mice.
Kandarian SC; Nosacka RL; Delitto AE; Judge AR; Judge SM; Ganey JD; Moreira JD; Jackman RW
J Cachexia Sarcopenia Muscle; 2018 Dec; 9(6):1109-1120. PubMed ID: 30270531
[TBL] [Abstract][Full Text] [Related]
26. Interference with Ca
Pin F; Minero VG; Penna F; Muscaritoli M; De Tullio R; Baccino FM; Costelli P
Front Physiol; 2017; 8():213. PubMed ID: 28469577
[TBL] [Abstract][Full Text] [Related]
27. Mitochondrial Metabolism in Cancer Cachexia: Novel Drug Target.
Dave DT; Patel BM
Curr Drug Metab; 2019; 20(14):1141-1153. PubMed ID: 31418657
[TBL] [Abstract][Full Text] [Related]
28. Mitochondrial Dysfunction in Cancer Cachexia: Impact on Muscle Health and Regeneration.
Beltrà M; Pin F; Ballarò R; Costelli P; Penna F
Cells; 2021 Nov; 10(11):. PubMed ID: 34831373
[TBL] [Abstract][Full Text] [Related]
29. Aerobic Exercise and Pharmacological Treatments Counteract Cachexia by Modulating Autophagy in Colon Cancer.
Pigna E; Berardi E; Aulino P; Rizzuto E; Zampieri S; Carraro U; Kern H; Merigliano S; Gruppo M; Mericskay M; Li Z; Rocchi M; Barone R; Macaluso F; Di Felice V; Adamo S; Coletti D; Moresi V
Sci Rep; 2016 May; 6():26991. PubMed ID: 27244599
[TBL] [Abstract][Full Text] [Related]
30. Molecular therapeutic strategies targeting pancreatic cancer induced cachexia.
Yakovenko A; Cameron M; Trevino JG
World J Gastrointest Surg; 2018 Dec; 10(9):95-106. PubMed ID: 30622678
[TBL] [Abstract][Full Text] [Related]
31. Megestrol acetate improves cardiac function in a model of cancer cachexia-induced cardiomyopathy by autophagic modulation.
Musolino V; Palus S; Tschirner A; Drescher C; Gliozzi M; Carresi C; Vitale C; Muscoli C; Doehner W; von Haehling S; Anker SD; Mollace V; Springer J
J Cachexia Sarcopenia Muscle; 2016 Dec; 7(5):555-566. PubMed ID: 27239419
[TBL] [Abstract][Full Text] [Related]
32. The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia.
Bonetto A; Rupert JE; Barreto R; Zimmers TA
J Vis Exp; 2016 Nov; (117):. PubMed ID: 27929469
[TBL] [Abstract][Full Text] [Related]
33. Role of PARP activity in lung cancer-induced cachexia: Effects on muscle oxidative stress, proteolysis, anabolic markers, and phenotype.
Chacon-Cabrera A; Mateu-Jimenez M; Langohr K; Fermoselle C; García-Arumí E; Andreu AL; Yelamos J; Barreiro E
J Cell Physiol; 2017 Dec; 232(12):3744-3761. PubMed ID: 28177129
[TBL] [Abstract][Full Text] [Related]
34. A standardized herbal combination of Astragalus membranaceus and Paeonia japonica, protects against muscle atrophy in a C26 colon cancer cachexia mouse model.
Lee SB; Lee JS; Moon SO; Lee HD; Yoon YS; Son CG
J Ethnopharmacol; 2021 Mar; 267():113470. PubMed ID: 33068652
[TBL] [Abstract][Full Text] [Related]
35. PDK4 drives metabolic alterations and muscle atrophy in cancer cachexia.
Pin F; Novinger LJ; Huot JR; Harris RA; Couch ME; O'Connell TM; Bonetto A
FASEB J; 2019 Jun; 33(6):7778-7790. PubMed ID: 30894018
[TBL] [Abstract][Full Text] [Related]
36. Molecular insights into mitochondrial dysfunction in cancer-related muscle wasting.
Antunes D; Padrão AI; Maciel E; Santinha D; Oliveira P; Vitorino R; Moreira-Gonçalves D; Colaço B; Pires MJ; Nunes C; Santos LL; Amado F; Duarte JA; Domingues MR; Ferreira R
Biochim Biophys Acta; 2014 Jun; 1841(6):896-905. PubMed ID: 24657703
[TBL] [Abstract][Full Text] [Related]
37. Antioxidant supplementation accelerates cachexia development by promoting tumor growth in C26 tumor-bearing mice.
Assi M; Derbré F; Lefeuvre-Orfila L; Rébillard A
Free Radic Biol Med; 2016 Feb; 91():204-14. PubMed ID: 26708754
[TBL] [Abstract][Full Text] [Related]
38. Mitophagy-mediated inflammation and oxidative stress contribute to muscle wasting in cancer cachexia.
Zhang Z; Tan S; Li S; Cheng Y; Wang J; Liu H; Yan M; Wu G
J Clin Biochem Nutr; 2023 Jul; 73(1):34-42. PubMed ID: 37534096
[TBL] [Abstract][Full Text] [Related]
39. Muscle wasting in cancer: the role of mitochondria.
Argilés JM; López-Soriano FJ; Busquets S
Curr Opin Clin Nutr Metab Care; 2015 May; 18(3):221-5. PubMed ID: 25769061
[TBL] [Abstract][Full Text] [Related]
40. Oral Treatment with the Ghrelin Receptor Agonist HM01 Attenuates Cachexia in Mice Bearing Colon-26 (C26) Tumors.
Villars FO; Pietra C; Giuliano C; Lutz TA; Riediger T
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28475119
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
